# Astellas Pharma US Inc. - Inspection Records

Source: https://www.keypedia.com/companies/astellas-pharma-us-inc/3bb1b330-7226-4071-b93b-2854ea7577cb

> Inspection records and compliance data for Astellas Pharma US Inc. in Northbrook, Illinois. Access full analysis and detailed observations.

---

## Details

- Name: Astellas Pharma US Inc.
- FEI Number: 1000036852
- City: Northbrook
- State: Illinois
- Country Name: United States
- Address Line 1: 2375 Waterview Dr
- Zip Code: 60062

## Related Documents

- [CRL - Astellas Pharma US Inc. - Unknown Date](https://www.keypedia.com/records/crl/astellas-pharma-us-inc/b1f7b509-ef48-44f3-b209-b9139becee10) — source: FDA, date: Invalid Date
- [CRL - Astellas Pharma US Inc. - Unknown Date](https://www.keypedia.com/records/crl/astellas-pharma-us-inc/38824898-0fd3-4732-a3c0-0e2b0ec6c098) — source: FDA, date: Invalid Date
- [CRL - Astellas Pharma US Inc. - Unknown Date](https://www.keypedia.com/records/crl/astellas-pharma-us-inc/1aec6d88-396b-4c11-a172-3b15f09904c9) — source: FDA, date: Invalid Date
- [FDA Inspection 1315968 - Astellas Pharma US Inc. - 2026-04-03](https://www.keypedia.com/records/fda_inspections/astellas-pharma-us-inc/a8cde674-aeb2-446c-85c3-37029386da2f) — source: FDA, date: April 3, 2026
- [FDA Inspection 1217117 - Astellas Pharma US Inc. - 2023-08-14](https://www.keypedia.com/records/fda_inspections/astellas-pharma-us-inc/712154c0-b326-4b40-863d-c8702746602f) — classification: Official Action Indicated (OAI), source: FDA, date: August 14, 2023
- [EIR - Astellas Pharma US Inc. - 2019-10-04](https://www.keypedia.com/records/eir/astellas-pharma-us-inc/5a4c8deb-12a4-437f-be85-1a83be409e2b) — source: FDA, date: October 4, 2019
- [FDA Inspection 1108572 - Astellas Pharma US Inc. - 2019-10-04](https://www.keypedia.com/records/fda_inspections/astellas-pharma-us-inc/8a1e2665-0d8f-4960-a284-f9e26947fe1b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 4, 2019
- [FDA Inspection 1058496 - Astellas Pharma US Inc. - 2018-06-22](https://www.keypedia.com/records/fda_inspections/astellas-pharma-us-inc/d7a88b57-15aa-4f49-89f8-856f64d6b476) — classification: No Action Indicated (NAI), source: FDA, date: June 22, 2018
- [FDA Inspection 1030399 - Astellas Pharma US Inc. - 2017-09-01](https://www.keypedia.com/records/fda_inspections/astellas-pharma-us-inc/0869f583-61a8-4b2d-a364-ba03c43c1105) — classification: No Action Indicated (NAI), source: FDA, date: September 1, 2017
- [FDA Inspection 1030399 - Astellas Pharma US Inc. - 2017-09-01](https://www.keypedia.com/records/fda_inspections/astellas-pharma-us-inc/a2413490-8e7c-4c79-8bc9-9f0da7204495) — classification: No Action Indicated (NAI), source: FDA, date: September 1, 2017
- [FDA Inspection 864055 - Astellas Pharma US Inc. - 2014-02-12](https://www.keypedia.com/records/fda_inspections/astellas-pharma-us-inc/88a143a1-368b-4771-8ddc-7c6957fb2c40) — classification: No Action Indicated (NAI), source: FDA, date: February 12, 2014
- [FDA Inspection 864055 - Astellas Pharma US Inc. - 2014-02-12](https://www.keypedia.com/records/fda_inspections/astellas-pharma-us-inc/13b35c64-6804-42c7-a532-c39739b9cc16) — classification: No Action Indicated (NAI), source: FDA, date: February 12, 2014
- [FDA Inspection 769358 - Astellas Pharma US Inc. - 2012-02-27](https://www.keypedia.com/records/fda_inspections/astellas-pharma-us-inc/7fa51065-c5d1-4851-b164-5fcb0c9dc8c3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 27, 2012
- [FDA Inspection 740776 - Astellas Pharma US Inc. - 2011-08-23](https://www.keypedia.com/records/fda_inspections/astellas-pharma-us-inc/c64556d7-cf41-47cd-acee-29b1b767f958) — classification: No Action Indicated (NAI), source: FDA, date: August 23, 2011

## Related Companies

- [SEAGEN INC.](https://www.keypedia.com/companies/seagen-inc/07c5dcb3-661e-4212-adfc-a00316850e38)
- [Viatris Inc.](https://www.keypedia.com/companies/viatris-inc/e65d242e-4279-4e07-992f-5f241792c2cf)
- [Eurofins Lancaster Laboratories, Inc](https://www.keypedia.com/companies/eurofins-lancaster-laboratories-inc/fdb282e8-01fc-4626-8794-1b7394ba0890)
- [Kobo Products, Inc](https://www.keypedia.com/companies/kobo-products-inc/998595c1-1a50-4600-8360-16c81c7e6d7b)
- [Pacific BioLabs](https://www.keypedia.com/companies/pacific-biolabs/3b9d5ef3-bc95-4934-9be0-40c8534a1bde)
- [Meridian Medical Technologies, LLC a Subsidiary of Kindeva Drug Delivery, L.P.](https://www.keypedia.com/companies/meridian-medical-technologies-llc-a-subsidiary-of-kindeva-drug-delivery-lp/00b844de-fb09-432d-96ab-31b8f7192a5d)
- [Lloyd Inc. of Iowa](https://www.keypedia.com/companies/lloyd-inc-of-iowa/b4573054-1b28-4619-88ea-c42615aede75)
- [WuXi AppTec Inc.](https://www.keypedia.com/companies/wuxi-apptec-inc/9d289339-3edc-4d2e-aacb-4d849335e75d)
- [Charles River Laboratories Cleveland, Inc.](https://www.keypedia.com/companies/charles-river-laboratories-cleveland-inc/1fb9e1d5-9a07-49aa-8436-06a067e5c1a9)
- [New Jersey Laboratories](https://www.keypedia.com/companies/new-jersey-laboratories/d310e635-49c8-4881-97d4-757fe831e691)

## Related Officers

- [Jennifer M. LaMora](https://www.keypedia.com/people/jennifer-m-lamora/d4318f7e-ae47-468f-ab99-8621e9bc3664)
- [company_representative](https://www.keypedia.com/people/kenji-tabata/037a7140-1eb4-44bb-8200-1a5a06c87646)
- [company_representative](https://www.keypedia.com/people/kenji-yasukawa/608edc38-77eb-41e5-a7bf-2631f03175ca)
- [Sarah Groenendal, M.S., RAC](https://www.keypedia.com/people/sarah-groenendal-ms-rac/318f7594-c615-4212-bdba-b89a4ed8d975)